A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

925

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

May 3, 2021

Study Completion Date

January 20, 2023

Conditions
Respiratory Syncytial Virus Infections
Interventions
DRUG

MEDI8897

Anti-RSV monoclonal antibody with an extended half-life

DRUG

Palivizumab

Approved anti-RSV monoclonal antibody

Trial Locations (128)

1004

Research Site, Riga

1096

Research Site, Budapest

1200

Research Site, Brussels

1309

Research Site, Sofia

1403

Research Site, Caen

1407

Research Site, Sofia

2013

Research Site, Soweto

2112

Research Site, Johannesburg

2193

Research Site, Johannesburg

3400

Research Site, Montana

3526

Research Site, Miskolc

4000

Research Site, Plovdiv

4003

Research Site, Plovdiv

4032

Research Site, Debrecen

4400

Research Site, Pazardzhik

5000

Research Site, Veliko Tarnovo

5800

Research Site, Pleven

6000

Research Site, Kecskemét

6500

Research Site, Baja

7002

Research Site, Rousse

7505

Research Site, Cape Town

7800

Research Site, Cape Town

8011

Research Site, Christchurch

8036

Research Site, Graz

8800

Research Site, Sliven

9000

Research Site, Ghent

11501

Research Site, Mineola

13015

Research Site, Marseille

13210

Research Site, Syracuse

13419

Research Site, Tallinn

14710

Research Site, Prague

15355

Research Site, Ansan-si

16499

Research Site, Suwon

20016

Research Site, Washington D.C.

21000

Research Site, Vinnytsia

22902

Research Site, Charlottesville

25198

Research Site, Lleida

26506

Research Site, Morgantown

27710

Research Site, Durham

27834

Research Site, Greenville

28046

Research Site, Madrid

28223

Research Site, Pozuelo de Alarcón

28660

Research Site, Boadilla del Monte

28911

Research Site, Leganés

29004

Research Site, Málaga

29607

Research Site, Greenville

29609

Research Site, Brest

30322

Research Site, Atlanta

33000

Research Site, Bordeaux

33100

Research Site, Tampere

35100

Research Site, Izmir

37126

Research Site, Verona

38043

Research Site, Grenoble

39216

Research Site, Jackson

40022

Research Site, Sumy

40202

Research Site, Louisville

41380

Research Site, Kocaeli

43007

Research Site, Tarragona

43205

Research Site, Columbus

45229

Research Site, Cincinnati

46202

Research Site, Indianapolis

46617

Research Site, South Bend

48259

Research Site, Kaunas

49006

Research Site, Dnipro

50161

Research Site, Kaunas

50266

Research Site, West Des Moines

51014

Research Site, Tartu

56126

Research Site, Pisa

58001

Research Site, Chernivtsі

60611

Research Site, Chicago

61093

Research Site, Kharkiv Region

62290

Research Site, Cuernavaca

64046

Research Site, Pau

65031

Research Site, Odesa

65201

Research Site, Columbia

67227

Research Site, Frankenthal

68161

Research Site, Mannheim

69677

Research Site, Bron

76014

Research Site, Ivano-Frankivsk

78411

Research Site, Corpus Christi

80045

Research Site, Aurora

80054

Research Site, Amiens

80922

Research Site, Colorado Springs

84041

Research Site, Layton

84790

Research Site, St. George

90027

Research Site, Los Angeles

90723

Research Site, Paramount

90806

Research Site, Long Beach

91790

Research Site, West Covina

91950

Research Site, National City

92804

Research Site, Anaheim

94010

Research Site, Créteil

98105

Research Site, Seattle

150003

Research Site, Yaroslavl

191025

Research Site, Saint Petersburg

193312

Research Site, Saint Petersburg

197341

Research Site, Saint Petersburg

420012

Research Site, Kazan'

614066

Research Site, Perm

630089

Research Site, Novosibirsk

T6G 1C9

Research Site, Edmonton

V6H 3V4

Research Site, Vancouver

04103

Research Site, Leipzig

918-8503

Research Site, Fukui-shi

813-0017

Research Site, Fukuoka

806-8501

Research Site, Kitakyusyu-shi

371-0811

Research Site, Maebashi

336 8522

Research Site, Saitama Shi

157-8535

Research Site, Setagaya-ku

LV-5201

Research Site, Jēkabpils

LV1002

Research Site, Riga

06720

Research Site, México

85 168

Research Site, Bydgoszcz

80-214

Research Site, Gdansk

30-348

Research Site, Krakow

31-624

Research Site, Krakow

51-169

Research Site, Wroclaw

0087

Research Site, Pretoria

0101

Research Site, Pretoria

06351

Research Site, Seoul

03010

Research Site, Alicante

03203

Research Site, Elche

08190

Research Site, Sant Cugat del Vallès

118 83

Research Site, Stockholm

01330

Research Site, Adana

LE3 9QP

Research Site, Leicester

W2 1NY

Research Site, London

NG7 2UH

Research Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY